Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Yi Wang
Weill Medical Coll of Cornell Univ, Department: Radiation Diagnostic/oncology
Should you be removed from our database? Contact us at [email protected]. Read more below.
MedImageMetric
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The long term objective of this research is to reliable, sensitive and accurate quantitative midbrain iron mapping using noninvasive magnetic resonance imaging, which can be used as an imaging biomarker for assessing progression and monitoring therapy of Parkinson’s disease. Specific aims:
1. Develop a noninvasive and accurate midbrain iron mapping based on QSM.
2. Validate noninvasive measurement of substantia nigra iron using elemental analysis and immunohistochemistry.
3. Establish that QSM is more sensitive than R2* for nigral iron mapping in monitoring PD iron chelation therapy.
Dr. Wang is co-inventor of the QSM technology used in this study. Cornell recently licensed the technology to MedImageMetric. Dr. Wang has equity in the company.
Quantitative mapping of substantia nigra iron in Parkinson's Disease
The long term objective of this proposed research is to reliable, sensitive and accurate quantitative midbrain iron mapping using noninvasive magnetic resonance imaging, which can be used as an imaging biomarker for assessing progression and monitoring therapy of Parkinson's disease.
Filed on December 19, 2017.
Tell us what you know about Yi Wang's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Yi Wang filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Yi Wang | Weill Medical Coll of Cornell Univ | Conflict of Interest | MedImageMetric, LLC | $10,000 - $19,999 |
| Yi Wang | Weill Medical Coll of Cornell Univ | Conflict of Interest | MedImageMetric | $10,000 - $19,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.